Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedSeveral key resources and links related to genetics and clinical trials have been removed, including MedlinePlus and DailyMed, which may impact access to important health information.SummaryDifference4%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to genetics, clinical trials, and treatment information, while removing the previous version 2.12.1.SummaryDifference4%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.